TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent).

Trial Profile

TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent).

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jan 2012

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Diabetic angiopathies
  • Focus Therapeutic Use
  • Acronyms TITANIC-XV
  • Most Recent Events

    • 13 Jan 2012 Additional trial location (Finland) and actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 13 Jan 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 11 Nov 2011 Results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top